Literature DB >> 7833261

Iron chelators induce apoptosis in proliferating cells.

D Hileti1, P Panayiotidis, A V Hoffbrand.   

Abstract

The iron chelators 1,2-dimethyl-3-hydroxypyrid-4-one (L1) and desferrioxamine (DFO) were found to induce apoptosis of proliferating activated T-lymphocytes and of the promyelocytic cell line HL60, but not of resting peripheral blood lymphocytes or granulocytes. The induction of apoptosis was quantified by propidium iodide staining of apoptotic/dead cells and flow cytometry. In activated T-lymphocytes incubated with the chelators at equivalent iron-binding concentrations (300 microM L1 or 100 microM DFO) for 24 h, L1 caused a 54% increase in cell death and DFO a 57% increase. In HL60 cells L1 caused a 50% increase in cell death and DFO a 40% increase. DNA cytofluorometry of HL60 cells treated with either chelator showed an increase in the percentage of cells with hypodiploid DNA content. Presaturation of the chelators with ferric chloride abrogated these effects. L1 and DFO did not induce apoptosis in resting peripheral blood lymphocytes or granulocytes, even after 48 h of incubation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7833261     DOI: 10.1111/j.1365-2141.1995.tb08927.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  32 in total

1.  Unexpected effects of albumin on apoptosis induction by deferoxamine in vitro.

Authors:  J Kovár; J D Kemp
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

2.  Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.

Authors:  Anthony Kicic; Anita C G Chua; Erica Baker
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 3.  Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.

Authors:  J A Barman Balfour; R H Foster
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

4.  Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1.

Authors:  Yu Yu; Des R Richardson
Journal:  J Biol Chem       Date:  2011-03-05       Impact factor: 5.157

5.  The effects of iron deficiency on neutrophil/monocyte apoptosis in children.

Authors:  S G Berrak; M Angaji; E Turkkan; C Canpolat; C Timur; E Eksioglu-Demiralp
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

Review 6.  Air pollutants disrupt iron homeostasis to impact oxidant generation, biological effects, and tissue injury.

Authors:  Andrew J Ghio; Joleen M Soukup; Lisa A Dailey; Michael C Madden
Journal:  Free Radic Biol Med       Date:  2020-02-21       Impact factor: 7.376

7.  The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.

Authors:  F X Weilbach; A Chan; K V Toyka; R Gold
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

8.  Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin.

Authors:  Leman Yalcintepe; Emre Halis
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

9.  Purification of Legiobactin and importance of this siderophore in lung infection by Legionella pneumophila.

Authors:  Kimberly A Allard; Jenny Dao; Prakash Sanjeevaiah; Kessler McCoy-Simandle; Christa H Chatfield; David S Crumrine; Domenic Castignetti; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

10.  A Fulvic Acid-like Substance Participates in the Pro-inflammatory Effects of Cigarette Smoke and Wood Smoke Particles.

Authors:  David H Gonzalez; Joleen M Soukup; Michael C Madden; Michael Hays; Jon Berntsen; Suzanne E Paulson; Andrew J Ghio
Journal:  Chem Res Toxicol       Date:  2020-03-27       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.